Patent · US Active

Cell and therapeutical and diagnostical methods based thereon

US8722045B2 · kind B2 · utility

0Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 2010
Grant dateMay 13, 2014
Priority date
Expiry dateJun 9, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a novel cell derived from the human body, where said cell comprises a Clever-1 receptor; to a method for affecting the immune system of an individual and for treatment of diseases or conditions related to the function of the immune system and to methods for screening of cancer patients that may respond to an anti-Clever-1 therapy or for diagnosing of a pregnancy complication or for estimating the risk of such complication in a pregnant woman.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.